StudiCare Mindfulness - Randomized controlled trial to evaluate adherence and effectiveness of two Persuasive Design-optimized versions of an Internet-based mindfulness intervention

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

DRKS

Registry ID

DRKS00030975

Enrollment

399

Registered

2023-01-30

Start date

2023-01-17

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

healthy sample

Interventions

Group 1: Basic version: Internet-based mindfulness intervention based on Acceptance Commitment Therapy and Mindfulness-Based Stress Reduction. Consists of 5 core modules and two additional modules tha

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Student status, sufficient knowledge of German/English, informed consent, Internet access.

Exclusion criteria

Exclusion criteria: above average mindfulness (FMI > 37)

Design outcomes

Primary

Measure	Time frame
Adherence (number of completed modules)	—

Secondary

Measure	Time frame
Mindfulness (FMI), Depression (PHQ-9), anxiety (GAD-7), stress (PSS-4), wellbeing (WHO-5), intervention satisfaction (CSQ-8), adherence (number of completed modules) and acceptance (self-developed questionnaire), various other measures of adherence (e.g., module usage time, login count, number of completed entries in the mindfulness diary, use of buddy feature), usability (SUS), self-constructed questionnaires (e.g., to evaluate persuasive design elements), risks and side effects; data collection before (t0), 4 weeks after (t1; intermediate), 8 weeks after (t2; post-intervention) and 6 months after (Follow-Up, t3) randomisation	—

Measure

Time frame

Mindfulness (FMI), Depression (PHQ-9), anxiety (GAD-7), stress (PSS-4), wellbeing (WHO-5), intervention satisfaction (CSQ-8), adherence (number of completed modules) and acceptance (self-developed questionnaire), various other measures of adherence (e.g., module usage time, login count, number of completed entries in the mindfulness diary, use of buddy feature), usability (SUS), self-constructed questionnaires (e.g., to evaluate persuasive design elements), risks and side effects; data collection before (t0), 4 weeks after (t1; intermediate), 8 weeks after (t2; post-intervention) and 6 months after (Follow-Up, t3) randomisation

—

Countries

Austria, Germany, Switzerland

Contacts

Public ContactHarald Baumeister

Universität Ulm, Abteilung für Klinische Psychologie und Psychotherapie

harald.baumeister@uni-ulm.de+49 731 50 32800

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026